Literature DB >> 2824671

Single amino acid substitution of Sendai virus at the cleavage site of the fusion protein confers trypsin resistance.

M Itoh1, H Shibuta, M Homma.   

Abstract

Amino acid sequences of fusion (F) proteins of two trypsin-resistant mutants of Sendai virus, TR-2 and TR-5, were deduced from nucleotide analysis of cDNA encoding the F gene and were compared with that of the trypsin-sensitive wild-type Sendai virus. In both mutants, amino acid substitutions were found at residues 116 (Arg----Ile), the cleavage site of the F protein, and 109 (Asn----Asp). Two trypsin-sensitive revertants, TSrev-52 and TSrev-58, derived from TR-5 were both activated by trypsin similarly to the wild-type virus and had a single amino acid reversion from Ile to Arg at residue 116, leaving Asp as before at residue 109. These results indicate that the trypsin sensitivity of Sendai virus can be changed by a single amino acid substitution at the cleavage site of the F protein and a mutation from Arg to Ile is responsible for the acquisition of resistance to trypsin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824671     DOI: 10.1099/0022-1317-68-11-2939

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Pneumopathogenicity of a Sendai virus protease-activation mutant, TCs, which is sensitive to trypsin and chymotrypsin.

Authors:  M Itoh; T D Ming; T Hayashi; Y Mochizuki; M Homma
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

2.  Comparison of protective effects of serum antibody on respiratory and systemic infection of Sendai virus in mice.

Authors:  M Tashiro; K Tobita; J T Seto; R Rott
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function.

Authors:  J A Beeler; K van Wyke Coelingh
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

4.  Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites.

Authors:  K V Coelingh; C C Winter
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

Review 5.  Protease-dependent virus tropism and pathogenicity.

Authors:  Y Nagai
Journal:  Trends Microbiol       Date:  1993-06       Impact factor: 17.079

6.  A protease activation mutant, MVCES1, as a safe and potent live vaccine derived from currently prevailing Sendai virus.

Authors:  X L Wang; M Itoh; H Hotta; M Homma
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

7.  A field isolate of Sendai virus: its high virulence to mice and genetic divergence form prototype strains.

Authors:  T Sakaguchi; K Kiyotani; M Sakaki; Y Fujii; T Yoshida
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.

Authors:  M Tashiro; Y Yokogoshi; K Tobita; J T Seto; R Rott; H Kido
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Pneumopathogenicity in mice of a Sendai virus mutant, TSrev-58, is accompanied by in vitro activation with trypsin.

Authors:  Y Mochizuki; M Tashiro; M Homma
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  Cell-mediated immunity induced in mice after vaccination with a protease activation mutant, TR-2, of Sendai virus.

Authors:  M Tashiro; Y Fujii; K Nakamura; M Homma
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.